|
Post by sportsrancho on Mar 28, 2017 6:08:41 GMT -5
|
|
|
Post by sportsrancho on Mar 28, 2017 6:09:54 GMT -5
|
|
|
Post by dreamboatcruise on Mar 28, 2017 8:20:49 GMT -5
Expensive and unpopular. MannKind's CEO and Board of Directors need to wake up. It seems almost criminal how they have priced Afrezza and it's, IMHO, a dishonor to Alfred E Mann. Especially now that we're learning that Afrezza works best when administered with two doses (at the beginning of the meal, followed by a second adjustment dose) the cost of this treatment at the current prices is outrageous. <img src="//storage.proboards.com/forum/images/smiley/superangry.png" alt=" " class="smile" contenteditable="false" text=" " Do M&M know something they are not revealing to shareholders? I can't imagine Matt would do anything AL would disapprove of. If Matt has some way of getting Al's opinion on operations today, then yes, Matt is hiding something big from us.
|
|
|
Post by sportsrancho on Mar 28, 2017 8:34:45 GMT -5
|
|